Outcome
    Limited

    Probiotics for Pancreatic Enzyme Support

    Probiotics may help small intestinal bacterial overgrowth that accompanies pancreatic disease, but do not replace enzymes.

    Overview

    Probiotics may help small intestinal bacterial overgrowth that accompanies pancreatic disease, but do not replace enzymes.

    Verdict

    Insufficient evidence

    How It Works

    Certain strains reduce bacterial overgrowth and improve mucosal barrier function, addressing a common comorbidity in exocrine insufficiency.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Strain-specific; discuss with a clinician in pancreatic disease
    Expected timeframe
    4-8 weeks

    Protocol

    form
    Not applicable. Pancreatic enzyme replacement therapy - pancreatin, prescribed as Creon or equivalent - is the treatment for exocrine pancreatic insufficiency, dosed in lipase units per meal
    duration
    Not applicable
    co factor
    Evidence is insufficient and the premise is mistaken. Probiotic bacteria produce some digestive enzymes of their own, which is the origin of the claim, but they do not stimulate pancreatic acinar secretion, do not replace pancreatic lipase, protease or amylase in the quantities required for digestion, and no trial has shown improvement in pancreatic function tests, faecal elastase, fat absorption or symptoms of exocrine pancreatic insufficiency. Trials of probiotics in acute pancreatitis have been conducted, and the largest - PROPATRIA - found significantly increased mortality in the probiotic arm, which is the most important finding in this area.
    titration
    Not applicable to probiotics. Enzyme replacement is titrated by a clinician, typically starting around 40,000-50,000 lipase units with meals
    starting dose
    Not established. Probiotics have not been shown to support pancreatic exocrine function at any dose

    Evidence

    What the studies say

    Evidence in chronic pancreatitis is scarce, and one trial in severe acute pancreatitis found increased mortality with a multi-strain preparation, making caution appropriate in acute illness.

    Efficacy of a multi-strain probiotic on digestive symptoms and enzyme-related maldigestion: a randomized controlled trial

    Score: 6/10
    2015
    rct
    n=40

    Ojetti V, Ianiro G, Tortora A +3 more

    Probiotic supplementation reduced bloating and flatulence scores significantly versus placebo

    View source

    Safety

    Caveats

    Avoid in severe acute pancreatitis and in critically ill or immunocompromised patients.

    Less likely to help if

    Everyone - probiotics do not affect pancreatic enzyme function and are harmful in acute pancreatitis.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.